Effects of abciximab pretreatment in patients with acute myocardial infarction undergoing primary angioplasty
- 1 September 2002
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 90 (5) , 533-536
- https://doi.org/10.1016/s0002-9149(02)02530-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Comparison of Angioplasty with Stenting, with or without Abciximab, in Acute Myocardial InfarctionNew England Journal of Medicine, 2002
- ST segment resolution as a tool for assessing the efficacy of reperfusion therapyJournal of the American College of Cardiology, 2001
- Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial InfarctionNew England Journal of Medicine, 2001
- Abciximab Improves Both Epicardial Flow and Myocardial Reperfusion in ST-Elevation Myocardial InfarctionCirculation, 2000
- Comparison of the predictive value of ST segment elevation resolution at 90 and 180min after start of streptokinase in acute myocardial infarction. A substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4 StudyEuropean Heart Journal, 1999
- Randomized, Placebo-Controlled Trial of Platelet Glycoprotein IIb/IIIa Blockade With Primary Angioplasty for Acute Myocardial InfarctionCirculation, 1998
- Effect of Reperfusion on Biventricular Function and Survival after Right Ventricular InfarctionNew England Journal of Medicine, 1998
- Extent of early ST segment elevation resolution: A simple but strong predictor of outcome in patients with acute myocardial infarctionJournal of the American College of Cardiology, 1994
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjectsJournal of the American College of Cardiology, 1985